|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Neurophysiol (April 1, 2003). 10.1152/jn.00943.2002
Submitted on Submitted 23 October 2002; accepted in final form 25 November 2002
7 Nicotinic Receptors
Department of Pharmacology and Therapeutics, University of Florida College of Medicine, University of Florida, Gainesville, Florida 32610-0267
| |
ABSTRACT |
|---|
|
|
|---|
Uteshev, Vladimir V.,
Edwin M. Meyer, and
Roger L. Papke.
Regulation of Neuronal Function by Choline and 4OH-GTS-21 Through
7 Nicotinic Receptors.
J. Neurophysiol. 89: 1797-1806, 2003.
A unique feature of
7 nicotinic
acetylcholine receptor physiology is that, under normal physiological
conditions,
7 receptors are constantly perfused with their natural
selective agonist, choline. Studying neurons of hypothalamic
tuberomammillary (TM) nucleus, we show that choline and the selective
7 receptor agonist 4OH-GTS-21 can regulate neuronal functions
directly, via activation of the native
7 receptors, and indirectly,
via desensitizing those receptors or transferring them into a state
"primed" for desensitization. The direct action produces
depolarization and thereby increases the TM neuron spontaneous firing
(SF) rate. The regulation of the spontaneous firing rate is robust in a
nonphysiological range of choline concentrations >200 µM. However,
modest effects persist at concentrations of choline that are likely to
be attained perineuronally under some conditions (20-100 µM). At
high physiological concentration levels, the indirect choline action
reduces or even eliminates the responsiveness of
7 receptors and
their availability to other strong cholinergic inputs. Similarly to
choline, 4OH-GTS-21 increases the TM neuron spontaneous firing rate via
activation of
7 receptors, and this regulation is robust in the
range of clinically relevant concentrations of 4OH-GTS-21. We conclude that factors that regulate choline accumulation in the brain and in
experimental slices such as choline uptake, hydrolysis of ACh, membrane
phosphatidylcholine catabolism, and solution perfusion rate influence
7 nAChR neuronal and synaptic functions, especially under
pathological conditions such as stroke, seizures, Alzheimer's disease,
and head trauma, when the choline concentration in the CSF is expected
to rise.
| |
INTRODUCTION |
|---|
|
|
|---|
Choline is an
essential physiological component of the cerebral spinal fluid (CSF)
and is important for the structural integrity of cell membranes,
acetylcholine (ACh) synthesis, and lipid and cholesterol transport and
metabolism. Neurons grown in culture have an absolute requirement for
choline (Eagle 1955
). Choline is accumulated in all
tissues via simple diffusion or specific carrier mechanisms
(Zeisel et al. 1980
). Under normal physiological conditions, the brain concentration of choline varies within a range of
10-20 µM and can rise to over 100 µM in a number of
pathophysiological conditions attributed to abnormal phospholipid
metabolism, such as neural trauma and chronic degenerative disorders,
including Alzheimer's disease (Farooqui and Horrocks
1994
; Jope and Gu 1991
; Klein et al.
1997
; Scremin and Jenden 1991
).
Recently, choline has been identified as a selective agonist of
7
nicotinic acetylcholine receptors (nAChR) (Albuquerque et al.
1997
; Mandelzys et al. 1995
; Papke et al.
1996
). Selective nicotinic
7 receptor activation has been
shown to exert a neurotrophic function in several systems, including
nerve growth factor (NGF)-differentiated PC12 cells that
otherwise undergo significant degeneration when serum and NGF are
removed (Martin et al. 1994
). Choline exerted a similar
neuroprotective activity in these cells, as well as in sympathetic
ganglion cultures that express pharmacologically defined
7 nicotinic
receptors (Koike et al. 1989
). The nicotinic nature of
the neuroprotection was demonstrated with the antagonist, mecamylamine,
and the neuroprotective role of intracellular calcium was indicated by
block with BAPTA (Koike et al. 1989
). Choline derived
from membrane phosphatidylcholine metabolism may protect
7-containing neurons selectively, accounting for the relative sparing of these receptors that has been observed in Alzheimer's disease compared with other types of nicotinic receptors (e.g.,
4
2; Lang and Henke 1983
). Therefore choline
generation during the hydrolysis of membrane phospholipids may provide
a general mechanism for local cytoprotective actions that are important for maintaining the integrity of
7 nAChR-containing pathways in the
brain during pathological conditions. Conversely, choline deficiency
expected in a typical electrophysiological experiment due to a rapid
solution perfusion may both reduce the ACh synthesis to a
nonphysiologically low level and also impede intrinsic cytoprotective mechanisms.
The TM nucleus of the posterior hypothalamus represents one of the
major brain centers involved in regulating multiple functions such as
the arousal state; brain energy metabolism; endocrine, autonomic, and
vestibular functions; locomotor activity; feeding; drinking; sexual
behavior; and analgesia (Schwartz et al. 1991
; Wada et al. 1991
). The physiological role of
7 nAChR
expression in TM neurons is not known, but the fact that the
7
subtype of nAChRs represents the only class of nicotinic receptors
natively expressed in these neurons (Papke et al. 2000a
;
Uteshev et al. 1996
) makes TM neurons unique and
suggests a possible functional link between cholinergic and
histaminergic systems in the posterior hypothalamus.
Previous studies have shown that TM neurons are natural pacemakers,
demonstrating spontaneous firing (SF) with a frequency of 1-8 Hz in
the absence of synaptic inputs in slices (Haas and Reiner
1988
; Llinas and Alonso 1992
) or after acute
dissociation (Taddese and Bean 2002
; Uteshev et
al. 1995
). A persistent sodium current component as well as the
slow calcium prepotentials were analyzed and are thought to be
responsible for the TM neuron SF (Llinas and Alonso
1992
; Stevens and Haas 1996
; Taddese and
Bean 2002
; Uteshev et al. 1995
). However, other
sources such as prolonged
7 nAChR activation may be involved in
facilitation of the SF. In the present set of experiments, TM neurons
were studied in slices and in acutely dissociated form to compare how
exposure to choline and 4OH-GTS-21, an
7-selective agonist, affect
neuronal excitability and
7 receptor availability to subsequent
cholinergic inputs.
| |
METHODS |
|---|
|
|
|---|
Chemicals
4OH-GTS-21 was synthesized and provided by Taiho Pharmaceuticals (Tokushima, Japan). All other chemicals were obtained from Sigma (St. Louis, MO).
Tissue preparation and solutions
Sprague-Dawley rats (Charles Rivers, Wilmington, MA) were used
in all experiments: 2- to 4-wk-old rats in slice patch-clamp experiments and 2- to 6-wk-old in experiments with acutely dissociated neurons. The level of expression of the functional
7 nAChRs in TM
neurons obtained from 2- to 6-wk-old rats was estimated by comparing
response amplitudes to applications of 0.5-1 mM ACh and was found to
be stable among the age groups used. The brains were removed after
decapitation and placed for 1-2 min in ice-cold oxygenated artificial
cerebrospinal fluid (ACSF) of the following composition (in mM): 126 NaCl, 3 KCl, 1.2 KH2PO4,
1.3 MgCl2, 2 CaCl2, 25 NaHCO3, and 10 glucose (pH 7.4) when bubbled with
carbogen (95% O2-5% CO2).
Two to three 300- to 400-µm-thick slices containing the TM nuclei
were prepared as described previously (Uteshev et al. 1995
,
2002
). Slices were then transferred to the storage chamber, where they were perfused with oxygenated ACSF for
10 h. For
patch-clamp slice experiments, slices were transferred to the recording
chamber just before the experiment. During the patch-clamp slice
experiment, slices were perfused with the oxygenated ACSF at the rate
of 1.5 ml/min. Slices prepared for the acute dissociation of TM neurons were transferred to 20 ml of oxygenated ACSF, and 1-2 mg/ml papain (papaya latex in crude form, 1.9 units/mg, Sigma) was added for 50-60
min at room temperature. After papain treatment, slices were washed
using the ACSF and were maintained in the ACSF at room temperature for
10 h (bubbled with carbogen).
Patch-clamp experiments with acutely dissociated neurons
Slices were placed in the experimental physiological solution
composed of the following composition (in mM): 150 NaCl, 3.5 KCl, 2 CaCl2, 10 HEPES, and 10 glucose (pH 7.4). Neurons
from the TM nucleus were isolated and identified as described
previously (Uteshev et al. 1995
, 2002
). Recording
patch-clamp pipettes with the resistance of 2-3 M
were polished and
filled with the following intracellular solution (in mM): 40 CsCl, 100 CsF, and 10 HEPES (pH 7.3). Data were acquired at 2-5 kHz with a
sampling rate of 50-100 µs and analyzed using pClamp8 software (Axon
Instruments, Union City, CA).
Patch-clamp experiments in slices
Slices were transferred to the recording chamber just before the
experiment. Whole cell recordings were conducted at room temperature
(22-24°C). A perfusion pump (INSTECH, Plymouth Meeting, PA) was used
to perfuse slices in the recording chamber with an adjustable rate
(0-1.5 ml/min). Syringe pumps were used to add experimental drugs to
the perfusion flow before it entered the recording chamber. The final
concentrations of drugs in the chamber were calculated based on the
rates of the pumps. Typically, the 1.5 ml/min rate of the main
perfusion flow was used, and a typical dilution factor for the drug
delivered by the syringe pump was 100. The time delay (1-1.5 min)
necessary to equilibrate solutions in the recording chamber was
determined in a set of separate experiments by a slice patch-clamp
recording from a TM neuron during bath applications of 100-300 µM
N-methyl-D-aspartate (NMDA) with or without 1 mM Mg2+ (data not shown). A
picospritzer with application pressure 10-30 PSI (Parker
Instrumentation, Cleveland, OH) was used to deliver drugs to neurons
via a pipette (3-7 M
) identical to those used for patch-clamp
recordings. The intracellular electrode solution contained the
following (in mM): 125 K-Glu, 1 KCl, 0.1 CaCl2, 2 MgCl2, 1 EGTA, 2 Mg-ATP, 0.3 Na-GTP, and 10 K-HEPES (pH 7.3). The data were recorded using pClamp 9 (beta) software
and a MultiClamp 700A amplifier (Axon Instruments).
High affinity [3H]methyllycaconitine binding
Hypothalami and hippocampi were rapidly dissected from killed 4- to 5-mo-old Sprague-Dawley albino rats and assayed for
nicotine-displaceable, high-affinity [3H]methyllycaconitine (MLA)
binding using a modification of the procedure of Davies et al.
(1999)
. The MLA concentration used in this study was 2.3 nM, a
concentration that is selective for
7 receptors. Tissues were
homogenized in 20 volumes of ice cold Krebs Ringer buffer (KRH; 118 mM
NaCl, 5 mM KCl, 10 mM glucose, 1 mM MgCl2, 2.5 mM
CaCl2, and 20 mM HEPES; pH 7.5) with a Polytron (setting 4 for 15 s). After two 1-ml washes with KRH at
20,000g, the membranes (10 or 90 µg protein for
hypothalamus or hippocampus, respectively) were incubated in 0.5 ml KRH
with 2.3 nM [3H]MLA (Tocris, Ellisville, MO)
for 60 min at 4°C with specified choline concentrations, ±5 mM
nicotine. Tissues were washed three times with 5 ml cold KRH by
filtration through Whatman GF/C filters that had been preincubated for
30 min with 0.5% polyethylenimine. They were assayed for radioactivity
using liquid scintillation counting. Nicotine-displaceable binding was
calculated for each choline concentration in triplicate in each
experiment, from which Ki values were
determined using the Prizm program, using a
Kd value of 1.8 nM for MLA
(Davies et al. 1999
).
| |
RESULTS |
|---|
|
|
|---|
Regulation of the TM neuron spontaneous firing by choline and 4OH-GTS-21
The TM neuron SF and its regulation by choline and 4OH-GTS-21 were
studied in whole cell patch-clamp slice experiments. We found that bath
applications of 80-320 µM choline and 3-9 µM 4OH-GTS-21 increased
the TM neuron SF frequency (Figs. 1 and
2). In the presence of 1.5 µM TTX, a
similar choline treatment produced a slow, sustained depolarization
(Fig. 2, A and B). Note that the slow
depolarization was not observed without TTX, when TM neurons exhibited
a robust SF (Figs. 1 and 2). Therefore it appeared that under
physiologically relevant conditions, TM neurons translate what would be
a slow depolarizing cholinergic signal into a sustained increase in the SF frequency. Bath perfusion of slices with muscarine (1-3 µM) did
not generate any detectable depolarizing effects or changes in SF (data
not shown), consistent with the results reported previously in this
preparation (Uteshev et al. 1996
). Since TM neurons
exclusively express
-bungarotoxin- and MLA-sensitive
7 nAChRs
(Papke et al. 2000a
; Uteshev et al. 1996
)
and do not require any synaptic inputs to fire spontaneously
(Haas and Reiner 1988
; Llinas and Alonso
1992
; Taddese and Bean 2002
; Uteshev et
al. 1995
), and both the effect of choline on SF and the slow
depolarizations were MLA-sensitive (Fig. 1, A and
B), we conclude that the observed effects were most likely
mediated by
7 nAChRs.
|
|
Preincubation of TM neurons in physiologically relevant concentrations of choline
Patch-clamp experiments were conducted in hypothalamic slices
using brief pulses (5-10 ms) of 200 µM ACh or 2 mM choline delivered to selected TM neurons via a picospritzer while the slice was perfused
with or without supplemental choline, and the resulting responses were
blocked by 60-120 nM MLA (Fig.
3A). (Note that 200 µM ACh
and 2 mM choline are equivalent in terms of
7 nAChR activation
capacity; Uteshev et al. 2002
.) The duration and the inter-stimulus interval of ACh applications were optimized in the
beginning of each experiment to generate stable responses, prior to the
addition of bath choline. Perfusion of slices with different
concentrations of choline or 4OH-GTS-21 reduced or completely desensitized control responses to higher concentrations of ACh or
choline. Specifically, while perfusion of slices with 10 µM choline
did not affect the shape and amplitude of responses to 200 µM ACh
(data not shown), preincubation in choline 20-80 µM for 2-5 min
decreased responses to 200 µM ACh in a concentration-dependent manner
(Fig. 3, B and C). Recovery from this inhibition
was full and rapid and occurred within the first 3-5 min of perfusion
of the slice with choline-free solution (Fig. 3B).
|
Since a picospritzer was used, the final agonist concentration that reached the selected TM neuron in a slice could not be determined precisely due to dilution, leak, and diffusion of agonist during and between applications. Therefore to better quantify the effects of choline inhibition, we conducted parallel experiments using a rapid agonist application system and acutely dissociated TM neurons, where agonist concentration in the vicinity of a selected neuron between and during agonist application, as well as the application durations themselves, could be well controlled and monitored.
Acutely dissociated TM neurons were patch-clamped and exposed to rapid
solution exchanges as described previously (Papke et al.
2000a
; Uteshev et al. 2002
). We determined the
fraction of a full
7 nAChR response to relatively high agonist
concentrations, such as 50 µM, 200 µM, and 1 mM ACh, under
conditions of prolonged or even tonic receptor
activation/desensitization that produced by physiologically relevant
low choline concentrations (10-100 µM). Consistent with the
observations made in hypothalamic slice recordings, preincubation of TM
neurons in low choline concentrations for 2-5 min reduced the current
responses to 0.05-1 mM ACh (Fig. 4).
|
Figure 4B summarizes experimental results showing that low
concentrations of choline (20-80 µM) would be sufficient to create a
sustained low level of receptor occupancy and a state primed for
desensitization that would make
7 nAChRs less effective in generating whole cell responses or excitatory postsynaptic currents (EPSCs). Interestingly, the degree of inhibition of control ACh responses during preincubation of TM neurons in 20-80 µM choline has
been relatively insensitive to ACh concentrations used for the control
application, i.e., 50 µM, 200 µM, or 1 mM. However, while it is
reasonable to suggest that responses to lower ACh concentrations (<50
µM) may be more susceptible to 20-80 µM choline-mediated inhibition, such responses would be difficult to quantify because of
the low signal-to-noise ratio.
We have previously reported that when high agonist concentrations are
applied, the
7 nAChR-mediated current reaches its peak before the
completion of the agonist exchange process (Uteshev et al.
2002
). Moreover, the response of
7 nAChRs to low agonist concentrations is slow and prolonged and may represent an important physiological modality of
7 nAChR function associated with a considerable calcium influx (Papke et al. 2000a
;
Uteshev et al. 2002
). Therefore as we suggested
previously, it may be advantageous to characterize
7 nAChR responses
by evaluating net charge under the late current phase (Uteshev
et al. 2002
). However, the results of the present study
indicate that both current net charge (Fig. 4B) and peak
(data not shown) are equally informative in how they describe the
choline-mediated inhibition of receptor responsiveness.
Preincubation of acutely dissociated TM neurons in low clinically relevant concentrations of 4OH-GTS-21
The low range for choline in CSF has been estimated to be
approximately 10 µM. This concentration would correspond roughly to
50 nM of 4OH-GTS-21, in terms of relative potencies estimated by the
current peak (i.e., nonequilibrium conditions) (Uteshev et al.
2002
). For 4OH-GTS-21, the range of 100-200 nM might also correspond to the threshold for seeing therapeutic effects. Therefore we sought to address the question of what fraction of a full
7 nAChR
response to a high agonist concentration would remain under conditions
of a constant presence of prolonged
7 nicotinic receptor activation,
comparable with what might be produced by a low borderline therapeutic
concentration of 4OH-GTS-21. Typical examples of a control
7 nAChR
response evoked by the application of 200 µM 4OH-GTS-21 and a
response after preincubation for 10 min or longer in 200 nM of
4OH-GTS-21 are shown in Fig. 5,
A and B. These estimates are consistent with the
results reported previously that demonstrated a 40-60% inhibition of
1 mM ACh-mediated transient responses after TM neurons were
preincubated in 1-3 µM ACh (Uteshev et al.1996
).
|
Note that the effects of 4OH-GTS-21 preincubation were different on the
transient peak current (45% inhibition) than on the late current,
which rises and then decays after the washout of the 200 µM
4OH-GTS-21 and return to 200 nM 4OH-GTS-21 (only 24% inhibition). This
suggests that the preincubation effects of low agonist concentrations
are most active at attenuating transient currents mediated by
7
nAChRs and yet may be relatively ineffectual at reducing currents in
the late phase of an evoked response, as the channels equilibrate
between open and desensitized states, even in the presence of high
concentrations of agonist.
We conducted parallel experiments to determine what fraction of a full
7 nAChR response to low and high concentrations of ACh (i.e., 50 µM and 1 mM) would remain during a preincubation of TM neurons in low
borderline therapeutic concentrations of 4OH-GTS-21, i.e., 200-400 nM
(Fig. 5, D and E). The results show that 200-400
nM 4OH-GTS-21 produced inhibition essentially equivalent to that
produced by 40-80 µM choline (compare Figs. 5E and
4B).
Effects of preincubating TM neurons in choline on the increase in TM neuron excitability
Figure 4 shows that preincubation of TM neurons in low
concentrations of choline reduces the responsiveness of
7 nAChRs and their availability to subsequent cholinergic inputs, and therefore, may
alter the effects of nicotinic agonists on the neuronal excitability (Fig. 1). Here we investigated how
7 nAChR desensitization, induced by low concentrations of choline, adjusts the sensitivity of TM neuron
SF to high concentrations of choline (300 µM). We
bath-applied choline (20-200 µM) for 1-3 min before bath-applying
300 µM choline to evoke the control increases in SF (Fig.
6). The results show that the 20-80 µM
choline-mediated reduction of
7 nAChR responses did not
significantly alter the 300 µM choline-mediated increase of the SF
rate (Fig. 6B). However, higher choline concentrations, such
as 200 µM choline, which themselves affected SF rate, did significantly reduce the increase in SF rate (Fig. 6B)
produced by applications of 300 µM choline. This observation suggests
that although 20-80 µM choline reduced the transient whole cell
7 nAChR responses to brief applications of ACh (0.05-1 mM), it preserved a sufficient activation capacity of the receptors to modulate the basic
excitability of TM neurons.
|
Choline displacement of radiolabeled MLA
The concentration response studies for the activation of rat
7
receptors by choline and 4OH-GTS-21 have been previously published (Papke and Papke 2002
). However, it is well documented
that the equilibrium affinities of nAChR for agonist may be
significantly higher than agonist potency for activation. Therefore
equilibrium binding experiments with hippocampal or hypothalamic
tissues were conducted to estimate the degree to which agonist binding
sites would be occupied by choline under our preincubation conditions. The data (data not shown) indicated that choline displaced radiolabeled MLA with Ki values of 59 ± 12 and 42 ± 6 µM in the hippocampal and hypothalamic tissues, respectively.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we show that choline and 4OH-GTS-21 can regulate TM
neuron function by activating or desensitizing
7 nAChRs. Prolonged
or phasic
7 nAChR activation may be involved in a direct regulation
of the SF. Strong facilitation of SF is associated with the
depolarization of TM neurons, which might occur in the brain under a
number of pathological conditions that raise the extracellular choline
concentration above 80-100 µM or conditions where there is a
relatively high level of an exogenous agonist. Presumably, choline and
4OH-GTS-21 modulate TM neuron SF by augmenting the excitatory action of
the persistent sodium channels, which are primarily responsible for
maintaining the firing of TM neurons (Llinas and Alonso
1992
; Taddese and Bean 2002
; Uteshev et
al. 1995
). The excitation of TM neurons, seen as an
7
receptor-mediated depolarization, can be obtained in
agonist-concentration ranges where
7 nAChR desensitization is
apparently not limiting. The distinct modality of
7 nAChR activation
associated with low agonist concentrations is characterized by minimal
slow receptor desensitization and thus also significant net charge
(Uteshev et al. 2002
). Moreover, our results indicate
that slight increases in the TM neuron SF rate produced by low agonist
concentrations are expected to last longer than robust increases in
excitation evoked by high agonist concentrations. This is consistent
with other reports of synaptic modulation by
7 nAChRs at low agonist
concentrations persisting over prolonged periods of time
(Mansvelder et al. 2002
).
7 nAChR agonists can modulate neuronal function indirectly by
promoting
7 nAChR desensitization or transferring receptors into a
state primed for desensitization. Each of these actions would be
predicted to alter the fraction of potential
7 nAChRs available for
information processing via fast synapses. The effects of prolonged
exposure to low concentrations of agonist (i.e., preincubation), which
inhibit the
7 nAChR responses to rapid applications of high agonist
concentrations, are likely to be physiologically important because any
strong cholinergic signals received by
7 nAChRs, either in the form
of diffuse volume transmission (Descarries et al. 1997
)
or fast cholinergic synapses (Alkondon et al. 1998
;
Frazier et al. 1998
; Gray et al. 1996
;
Hatton and Yang 2002
; Ji and Dani 2000
;
Radcliffe and Dani 1998
), will necessarily be received
over background effects of choline. It is important to note that the
effects that we observed with TM neurons in hypothalamic slices can be
generalized to other cell populations expressing high levels of
7
nAChRs, such as the interneurons of the hippocampus (C. J. Frazier, personal communication).
7 nAChRs have sometimes been characterized as "low-affinity"
neuronal nAChRs. In part, this is because the unique fast
desensitization of
7 nAChRs requires the use of high concentrations
of agonist to evoke large transient currents. However, using net charge
analysis, we have recently shown that effective concentrations for
channel activation are 10-fold lower than previously believed (the
EC50 values for choline and 4OH-GTS-21 are 415 and 1.6 µM, respectively; Papke and Papke 2002
;
Uteshev et al. 2002
). Additionally,
7 receptors have
been characterized as low affinity because they do not show the same
large increase in affinity on desensitization that has been detected in
equilibrium binding experiments with other subtypes of nAChR. For
example, while nicotine has an EC50 of 50 µM
for the activation of
4
2 receptors (Papke et al.
2000b
), in equilibrium binding experiments, nicotine binds with
a Kd of about 10 nM (Cairns and
Wonnacott 1988
; Reavill et al. 1988
). It has
been previously reported that the Ki
of 4OH-GTS-21 for the displacement of radiolabeled
-bungarotoxin was
170 nM (Meyer et al. 1998
), 9.4-fold lower than the
EC50 for receptor activation, suggesting that the
binding did not undergo the same affinity increase during membrane
preparation as seen with other receptor subtypes. To determine whether
this phenomenon was seen with other selective
7 nAChR agonists and antagonists, similar equilibrium binding experiments were conducted with choline and labeled MLA. These results indicated that choline displaced radiolabeled MLA with Ki
values of approximately 50 µM, a value which is also about eightfold
lower than the EC50 for
7 receptor activation,
suggesting that the relatively modest increase in affinity seen during
equilibrium binding studies with
7 nAChRs is independent of the
ligands selected.
The preincubation concentrations of choline and 4OH-GTS-21 that inhibit
transient (i.e., nonequilibrium) agonist-evoked responses roughly
correspond to the concentrations at which 50% equilibrium binding
would be expected. There are several potential hypotheses that would
account for this observation, including one that we proposed previously
to account for a variety of properties of
7 nAChRs. This hypothesis
states that (Papke et al. 2000a
) the open probability of
7 nAChRs is greatest for intermediate levels of fractional occupancy
(e.g., 2 or 3 of 5 possible agonist binding sites occupied), and that
receptors with higher levels of agonist occupancy are more likely to be
in closed or desensitized states than in the open state. This model
accounts for the fast transient current that occurs during the jump to
a saturating concentration of agonist (Papke et al.
2000a
; Uteshev et al. 2002
). It may also be used
to explain the effects of choline and 4OH-GTS-21 preincubations. We can
use the equilibrium affinity to predict the relative levels of agonist
occupancy among the receptors following preincubation. With 50% of all
agonist binding sites occupied, the predicted percentages of receptors
with 0, 1, 2, 3, 4, or 5 agonist binding sites occupied are 3%, 16%,
31%, 31%, 16%, and 3%, respectively. If this is the steady-state
occupancy before a jump to a higher (i.e., saturating) concentration of
agonist, then based on the model, approximately 50% (i.e., 31 + 16 + 3) of the receptors would already be in a state where more agonist
binding would not make them more likely to open. This could account for
the decrease in the amplitude of the transient current evoked by the
jump to high agonist concentration. Likewise, with 50% site occupancy, 20% of the receptors would be at the two highest levels of fractional agonist occupancy already, and may therefore represent the percentage of receptors preequilibrated into the slow desensitized state. This
value corresponds to the inhibition of the late current which arose and
then decayed with the washout of the 200 µM 4OH-GTS-21 following
preincubation with 200 nM 4OH-GTS-21 (Fig. 5C).
Numerous groups have used brain slice preparations to investigate the
role of
7 receptors in synaptic function (Alkondon et al.
1998
; Frazier et al. 1998
; Gray et al.
1996
; Hatton and Yang 2002
; Ji and Dani
2000
; Radcliffe and Dani 1998
). Ambient levels
of choline in the tissue has largely been an ignored parameter in these
experiments. Our data indicate that fluctuations in free choline
concentrations will modulate some
7 nAChR-mediated effects and
consequently, their physiological importance, in subtle manners, with
more dramatic effects likely under conditions that elevate extracellular choline. At typical bath perfusion rates (e.g., 2 ml/min), choline levels in the slice may fall to as low as one-third normal (V. V. Uteshev, R. L. Papke, and L. Prokai, unpublished observation), so that in a typical electrophysiological
experiment, in which brain slices are perfused with choline-free ACSF,
the basal
7 nAChR occupancy may be particularly low. Adding
physiologically relevant concentrations of choline to the perfusion
ACSF solutions may be appropriate in studies concerned with the
potential effects of decreases in receptor availability due to desensitization.
Choline is essential in the CNS for the biosynthesis of both ACh and
some membrane phospholipids. The level of ambient choline in the CSF is
normally below 20 µM due to a dynamic equilibrium involving
availability from the bloodstream and removal by low- and high-affinity
uptake mechanisms (Klein et al. 1992
). Our experiments show that low basal choline levels induce no more than 20% inhibition of
7 nAChR responsiveness to subsequent strong (i.e., 0.05-1 mM
ACh) cholinergic inputs. While, weaker cholinergic inputs (<50 µM
ACh) may be more sensitive to inhibitory effects of physiological choline, alternatively, there might be synergistic effects between physiological levels of choline and low levels of ACh resulting from
volume transmission (Descarries et al. 1997
) or the
decaying phase of strong cholinergic inputs. One function of baseline
choline levels might therefore be to tune cholinergic information
transfer among neurons in multiple ways. In some cases, basal choline
may have the effect of reducing cholinergic background noise and
enhancing the effects of volume transmission, and in other cases,
making
7 nAChRs less available for low-intensity cholinergic
signals, yet preserving the responsiveness of
7 nAChRs to strong
cholinergic inputs.
In addition to the low ambient concentrations of choline in the brain,
rapid transient increases in extracellular ACh concentrations and thus
proportionate increases in choline levels are expected as a result of
multiple synchronous releases of ACh from cholinergic varicosities in
the vicinity of synaptic or nonsynaptic specializations in the brain
areas packed with cholinergic fibers. Under basal conditions, in the
presence of a choline esterase inhibitor, the level of ACh detected by
microdialysis in the hippocampus is only about 10-fold lower than the
ambient choline level (Koppen et al. 1997
). This level
of ACh corresponds to the ACh that derives directly from the synaptic
activity in the hippocampus since when the synaptic release of ACh is
augmented by the inhibition of muscarinic autoreceptors with atropine,
ACh levels increase fivefold, and choline levels show a further twofold
increase (Koppen et al. 1997
).
While the significance of physiological fluctuations in choline
concentrations relative to
7 nAChR function remains to be more
carefully elucidated, our data do suggest several possibilities. The
tonic influx of low concentrations of calcium ions associated with
either nicotinic receptor activation or activation of other receptors
can be neuroprotective, so it is feasible that the basal activity
provided by extracellular choline may be additive with other
calcium-elevating systems to modulate cell survival, especially in
complex, multiple-receptor systems such as the brain. Additionally, while, the desensitization induced by low choline concentrations would
probably not impact most strong cholinergic signals by more than
10-20%, this effect would be significantly greater if choline concentrations were somehow elevated, either from hydrolysis of ACh or
from pathological conditions described below. Regarding ACh-hydrolysis,
any choline that diffused within or from synaptic sites would be likely
to modulate
7 nAChR function to a much greater extent than would be
seen with circulating choline concentrations. In particular, two
possibilities regarding this residual, high level of choline suggested
from our data are 1) transmission from rapid, repeated
cholinergic firing could be reduced by nAChR desensitization induced by
residual synaptic choline; and 2) intracellular calcium concentrations would likely be modulated both by choline that diffused
from the synapse to extrasynaptic nAChR receptors as well as by
cholinergic synaptic processes, making this a particularly complex system.
There are also a variety of other processes that have been found to
increase extracellular choline concentrations dramatically, including
NMDA receptor activation (Zapata et al. 1998
), cellular dysfunction, energy deprivation (Djuricic et al. 1991
),
and cell death by excitotoxicity (Gasull et al. 2000
) or
ischemia (Rao et al. 2000
). Cell death is well known to
lead to the breakdown of phosphatidylcholine, the principle plasma
membrane phospholipid, to choline and diacylglycerol, providing a large
source of the
7 nAChR agonist. All of these conditions that create
local elevations in choline may impact neuronal function through
7
nAChR receptors. It is intriguing to hypothesize that this choline may
be sufficient to protect other, local neurons from the same toxic
insult, although it should be noted that
3 h of
7 receptor
activation is required prior to most insults for neuroprotection to be
observed (Li et al. 1999
); this accounts for the
inability of localized choline to protect against ischemic damage in
stroke since there is no pretreatment interval in that condition
(Shimohama et al. 1998
).
It is interesting to note that
7 nAChR expressing neurons in the
hippocampus appear to be mostly spared in Alzheimer's disease, a
slowly progressive disorder, despite widespread and profound neuronal
loss in that region, as well as the loss of ascending cholinergic
synaptic inputs. Amyloid-induced neuronal dysfunction is hypothesized
to be a component of this disease, based on the accumulation of plaques
containing this peptide. Agonist induced activation of
7 receptors
prevents neurotoxicity induced by amyloid peptides in several model
systems in a manner that is blocked by selective
7 antagonists
(Kihara et al. 2001
; Shimohama and Kihara
2001
). Whether activation by physiologically relevant choline concentrations, or, more likely, choline from dying neurons, provides similar protection against Alzheimer's disease is a possibility that
remains to be ascertained. However, it should be noted that evaluating
the physiological significance of
7 receptor activation is
complicated by a variety of observations. For example,
7 antagonists and agonists respectively interfere with and improve memory related behaviors (Rezvani and Levin 2001
), yet
7 receptor
knockout mice appear to have few behavioral deficits (Paylor et
al. 1998
). Amyloid peptides that accumulate in Alzheimer's
disease have been reported to block
7 receptors at nanomolar
concentrations (Liu et al. 2001
). However, it has also
been suggested that amyloid peptides may activate
7 receptors at
picomolar concentrations (Dineley et al. 2002
).
Therefore it is not clear how choline-induced activation or
desensitization of
7 receptors would interact with these possibly dose-dependent actions of amyloid peptides, or whether this interaction would even remain constant throughout the course of the disease as
amyloid load increases. Nonetheless, our results allow us to hypothesize that high levels of extracellular choline found near dying
neurons in this disease may protect nAChR-expressing neurons in two
manners, both involving these receptors: 1) through
inactivation of nAChRs that are otherwise potential targets for
amyloid; and 2) tonically activating the few remaining
nondesensitized receptors, permitting a small calcium influx that is neuroprotective.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Lazlo Prokai for help measuring choline levels in brain slices and slice perfusate, A. Placzek and C. Stokes for comments on the manuscript, and Dr. Charles J. Frazier for helpful discussions. We also thank Taiho Pharmaceuticals for providing 4OH-GTS-21.
This work was supported by National Institutes of Health Grants NS-32888-02 and GM-57481-01A2.
| |
FOOTNOTES |
|---|
Address for reprint requests: R. L. Papke, Dept. of Pharmacology and Therapeutics, Univ. of Florida College of Medicine, 100267 JHMHSC 1600 SW Archer Rd., Univ. of Florida, Gainesville, FL 32610-0267 (E-mail: rpapke{at}college.med.ufl.edu).
| |
REFERENCES |
|---|
|
|
|---|
-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons.
J Neurosci
18:
8228-8235, 1998
7 nicotinic receptor activation in PC12 cells.
Brain Res
81:
218-225, 1999.
7 nicotinic receptors.
J Pharmacol Exp Ther
287:
918-925, 1998
7 subtype.
Neurosci Lett
213:
201-204, 1996[Web of Science][Medline].
4
2 receptor subtype.
J Neurochem
75:
204-216, 2000b[Web of Science][Medline].
)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.
Neuropharmacology
27:
235-241, 1988[Web of Science][Medline].
7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage.
Brain Res.
779:
359-363, 1998[Web of Science][Medline].This article has been cited by other articles:
![]() |
R. L. Papke, W. R. Kem, F. Soti, G. Y. Lopez-Hernandez, and N. A. Horenstein Activation and Desensitization of Nicotinic {alpha}7-type Acetylcholine Receptors by Benzylidene Anabaseines and Nicotine J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 791 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alkondon and E. X. Albuquerque Subtype-Specific Inhibition of Nicotinic Acetylcholine Receptors by Choline: A Regulatory Pathway J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 268 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Akk, L. S Milescu, and M. Heckmann Activation of heteroliganded mouse muscle nicotinic receptors J. Physiol., April 15, 2005; 564(2): 359 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Pomper, E. Phillips, H. Fan, D. J. McCarthy, R. A. Keith, J. C. Gordon, U. Scheffel, R. F. Dannals, and J. L. Musachio Synthesis and Biodistribution of Radiolabeled {alpha}7 Nicotinic Acetylcholine Receptor Ligands J. Nucl. Med., February 1, 2005; 46(2): 326 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, S. Guo-Ross, D. V. Lewis, D. Turner, A. M. White, W. A. Wilson, and H. S. Swartzwelder Dietary Prenatal Choline Supplementation Alters Postnatal Hippocampal Structure and Function J Neurophysiol, April 1, 2004; 91(4): 1545 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Frazier, B. W. Strowbridge, and R. L. Papke Nicotinic Receptors on Local Circuit Neurons in Dentate Gyrus: A Potential Role in Regulation of Granule Cell Excitability J Neurophysiol, June 1, 2003; 89(6): 3018 - 3028. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |